Achieve Safe & Targeted In Vivo Delivery of Payloads with Clarity in Regulations & Appropriate Models to Advance the Next Frontier of In Vivo Editing from Research to Clinic
July 9-11, 2024 | Boston, MA
Save up to $600 - Offer Ends this Friday, May 17!
Welcome to the 3rd In Vivo Cell Engineering & Gene Editing Summit!
The ONLY event focused on both cellular and genetic frontiers
As promising pre-clinical results continue to emerge, the shift from the βdreamβ of in vivo cell engineering and gene editing is rapidly becoming a reality, with numerous companies pushing towards the clinic.
The 3rd In Vivo Cell Engineering & Gene Editing Summit is an exclusive platform offering the latest advances in preclinical development, IND-enabling studies, first clinical data readouts, and more, while also providing clarity on the full in vivo landscape.
This is your chance to unite with industry giants like Capstan Therapeutics, Editas Medicine, NanoCell Therapeutics, Carisma Therapeutics, Mustang Bio, iECURE, and many others, for exclusive access to groundbreaking discoveries and networking opportunities, propelling your pipelines to new heights!
Key Highlights
Download the Full Agenda for More Information on:
-
-
-
- 15+ In Vivo Expert Speakers
- 2 Interactive Deep-Dive Workshops
- 8+ Hours of Industry Networking
- & Much More!
-
-
World-Class Speaker Faculty Includes
Adrian Bot
Chief Scientific Officer & Executive Vice President - Research & Development
Capstan Therapeutics